Log in Book a Demo

US Pharma & Biotech Cardiology - PPC Market Share Analysis May 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
repatha.com 63.96
repathahcp.com 14.87
vyndamax.com 2.58
bmscustomerconnect.com 1.85
veltassa.com 1.83
nexlizethcp.com 1.67
naomiw.com 1.36
nexlizet.com 1.25
thorne.com 1.13
1md.org 1.04
others 8.46

Copyright © Adthena. All rights reserved.

Repatha.com dominates with 63.96% click share, followed by Repathahcp.com at 14.87%. Others collectively hold 8.46%, while Vyndamax.com captures 2.58%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date repatha.com repathahcp.com bmscustomerconnect.com leqviohcp.com nexlizethcp.com veltassa.com leqvio.com vyndamax.com nexlizet.com vyndamax.pfizerpro.com
2025/05/01 43.27% 18.42% 10.37% 0% 0.84% 0% 0.6% 8.99% 0.27% 1.96%
2025/05/02 51.03% 21.02% 0.19% 0.29% 0.29% 2.08% 1.14% 5.18% 0.01% 3.11%
2025/05/03 60.7% 24.57% 0.39% 1.02% 0.2% 1.92% 2.02% 0.84% 0.01% 0.11%
2025/05/04 53.54% 22.95% 6.57% 0.8% 1.8% 0% 3.81% 4.1% 0.8% 3.85%
2025/05/05 51.39% 15.17% 11.21% 0.07% 3.27% 2.14% 0.72% 3.65% 3.3% 1.39%
2025/05/06 63.79% 16.95% 1.94% 0.02% 0.13% 0% 0.39% 2.85% 0% 2.84%
2025/05/07 64.84% 16.02% 3.82% 0.02% 1.51% 2.42% 0.59% 2.06% 0.57% 0.83%
2025/05/08 56.26% 25.01% 0.06% 0.04% 0.26% 1.45% 0.92% 2.22% 0.77% 0.9%
2025/05/09 70.12% 20.13% 0.04% 0.06% 0.1% 0% 0.82% 2.66% 0% 1.36%
2025/05/10 68.62% 17.11% 1.16% 0.04% 0% 0% 0.63% 2.86% 0% 1.55%
2025/05/11 61.64% 18.76% 0.03% 0.03% 1.68% 0% 1.72% 2.88% 1.01% 1.81%
2025/05/12 57.71% 17.45% 0% 0.02% 2.28% 6.88% 1% 3.77% 2.67% 2.68%
2025/05/13 60.22% 23.31% 0.04% 0.02% 2.16% 1.31% 0.69% 3.7% 2.13% 1.83%
2025/05/14 73.37% 14.1% 0.76% 0.02% 2.2% 0% 0.16% 2.32% 0.76% 1.35%
2025/05/15 54.93% 22.29% 0% 0.02% 2.04% 5.44% 2.08% 3.24% 2.54% 2.14%
2025/05/16 65.2% 24.22% 1.04% 0.22% 0.97% 0.94% 0.89% 2.06% 0.84% 1.07%
2025/05/17 64.5% 27.59% 0% 0.01% 0.71% 0.96% 2.06% 0.36% 0.32% 0.3%
2025/05/18 64.33% 25.06% 0% 0.14% 0.66% 0% 2.43% 0.87% 0.6% 0.98%
2025/05/19 65.03% 23.42% 0% 0.02% 0.19% 1.45% 1.38% 1.8% 0% 0.69%
2025/05/20 67.67% 25.59% 0% 0.05% 0.09% 0% 1.12% 2.21% 0% 0.79%
2025/05/21 72.07% 18.61% 0.75% 0.04% 0.02% 0% 0.98% 2.23% 0.59% 0.7%
2025/05/22 58.19% 25.98% 0.07% 0.4% 0.25% 0% 0.97% 2.91% 0.98% 1.39%
2025/05/23 52.4% 30% 0.01% 2.41% 1.33% 0% 1.18% 1.11% 0.48% 1.83%
2025/05/24 55.86% 23.06% 0.11% 2.54% 2.86% 0.84% 0.73% 3.12% 3.92% 1.87%
2025/05/25 55.12% 21% 0.01% 6.81% 3.1% 0% 2.19% 3.86% 2.35% 1.86%
2025/05/26 65.94% 19.14% 0.14% 2.66% 0.42% 1.45% 1.48% 1.65% 1.75% 1.21%
2025/05/27 66.27% 16.13% 0.01% 2.99% 2.98% 0% 0.75% 2.88% 1.75% 1.12%
2025/05/28 64.38% 14.62% 1.94% 0.95% 0.58% 2.91% 0.17% 3.84% 0.31% 2.14%
2025/05/29 48.42% 15.34% 0.03% 2.96% 3.92% 3.04% 0.41% 2.2% 1.04% 0.58%
2025/05/30 67.88% 14.97% 0.05% 0.91% 1.55% 1.24% 0.3% 2.68% 0% 2.55%
2025/05/31 66.88% 18.09% 3.58% 1.98% 1.89% 1.14% 1.08% 0.78% 0.28% 0.26%

Copyright © Adthena. All rights reserved.

Repatha.com led May with fluctuating dominance, peaking mid-month. Repathahcp.com showed consistent growth, while bmscustomerconnect.com remained low. Leqviohcp.com and nexlizethcp.com saw sporadic spikes. Vyndamax.com and vyndamax.pfizerpro.com had varied performances.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/05/01 19
2025/05/02 25
2025/05/03 20
2025/05/04 20
2025/05/05 24
2025/05/06 22
2025/05/07 20
2025/05/08 17
2025/05/09 16
2025/05/10 12
2025/05/11 18
2025/05/12 20
2025/05/13 24
2025/05/14 25
2025/05/15 23
2025/05/16 28
2025/05/17 30
2025/05/18 30
2025/05/19 28
2025/05/20 25
2025/05/21 28
2025/05/22 25
2025/05/23 31
2025/05/24 28
2025/05/25 21
2025/05/26 24
2025/05/27 18
2025/05/28 30
2025/05/29 31
2025/05/30 24
2025/05/31 25

Copyright © Adthena. All rights reserved.

In May 2025, advertiser numbers fluctuated, peaking at 31 on May 23 and 29. The month concluded with 25 advertisers, reflecting a dynamic landscape.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
leqviohcp.com 1.6%
thorne.com 1.25%
repatha.com 1.11%
bioyouthlabs.com 0.82%
repathahcp.com 0.56%
farxiga-hcp.com -0.42%
vyndamax.com -0.55%
veltassa.com -1.23%
farxiga.com -2.06%
bmscustomerconnect.com -2.25%

Copyright © Adthena. All rights reserved.

Thorne.com and leqviohcp.com saw notable click share increases, while bmscustomerconnect.com and farxiga.com experienced significant declines.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repatha.com repathahcp.com nexlizethcp.com leqviohcp.com naomiw.com 1md.org leqvio.com nexlizet.com thorne.com farxiga.com
2025/05/01 16.86% 20.96% 2.08% 0% 11.04% 2.76% 1.22% 0.84% 8.28% 0.23%
2025/05/02 25.62% 23.27% 0.47% 0.52% 8.55% 5.7% 2.1% 0.02% 14.26% 0.25%
2025/05/03 38.42% 28.73% 0.42% 2.1% 5.05% 5.05% 5.83% 0.02% 2.53% 3.17%
2025/05/04 40.44% 30.4% 3.81% 1.27% 0.85% 0% 4.77% 1.71% 0% 0.62%
2025/05/05 32.42% 20.57% 5.57% 0.14% 5% 2.5% 1.48% 5.57% 0% 0.44%
2025/05/06 39.87% 19.05% 0.32% 0.04% 2.72% 2.72% 0.9% 0% 0% 10.04%
2025/05/07 40.07% 21.64% 3.43% 0.03% 4.02% 2.01% 1.34% 1.2% 0% 6.2%
2025/05/08 45.92% 25.66% 1.13% 0.06% 0% 0% 1.79% 1.5% 0% 14.33%
2025/05/09 53.65% 25.9% 0.23% 0.11% 3.86% 3.86% 1.96% 0% 0% 1.78%
2025/05/10 50.3% 20.73% 0% 0.08% 0% 0% 1.46% 0% 0% 21.01%
2025/05/11 45.16% 22.89% 3.99% 0.04% 0% 0% 2.46% 2.53% 0% 7.22%
2025/05/12 44.61% 20.52% 4.28% 0.03% 0% 0.01% 1.91% 5.71% 0.01% 7.86%
2025/05/13 43.64% 28.23% 5.51% 0.03% 2.01% 0% 1.49% 3.59% 4.03% 0.89%
2025/05/14 47.13% 20.81% 6.77% 0.03% 4.96% 4.96% 0.38% 2.95% 0.01% 0.02%
2025/05/15 37.69% 26.09% 4.38% 0.02% 1.75% 3.49% 4.18% 4.38% 1.75% 0.01%
2025/05/16 44.74% 34.29% 3.41% 0.4% 0% 0% 2.39% 2.54% 0.01% 0%
2025/05/17 48.28% 33.33% 1.64% 0.01% 3.2% 1.6% 4.88% 0.95% 0.01% 0.01%
2025/05/18 48.8% 28.93% 2.1% 0.29% 1.63% 1.63% 5.18% 1.19% 3.27% 0.33%
2025/05/19 33.78% 19.17% 0.44% 0.02% 3.89% 2.59% 2.25% 0% 2.6% 0%
2025/05/20 54.06% 33.27% 0.19% 0.11% 0% 0% 2.67% 0% 1.79% 0.01%
2025/05/21 51.98% 27.29% 0.05% 0.06% 1.59% 1.59% 2.61% 1.29% 3.18% 0.32%
2025/05/22 40.96% 26.81% 0.85% 1.01% 3.57% 1.78% 2.06% 1.59% 0% 0%
2025/05/23 35.94% 30.93% 2.69% 4.27% 2.96% 2.96% 2.28% 0.66% 4.45% 1.08%
2025/05/24 37.37% 26.13% 6.11% 4.76% 1.2% 1.2% 1.52% 8.15% 1.2% 0%
2025/05/25 40.22% 25.55% 5.14% 12.22% 0% 1.74% 2.06% 3.74% 0% 0%
2025/05/26 46.74% 24.36% 1.4% 4.64% 1.66% 1.66% 2.41% 5.43% 0% 0%
2025/05/27 42.29% 20.64% 8.99% 5.67% 0% 0% 1.79% 4.5% 2.21% 0%
2025/05/28 35.23% 20.06% 1.61% 1.99% 4.35% 4.35% 0.41% 1.22% 6.53% 0%
2025/05/29 25.36% 12.61% 8.77% 4.4% 6.33% 6.33% 0.62% 1.28% 9.5% 0%
2025/05/30 41.12% 20.46% 4.76% 1.86% 6.19% 2.06% 0.71% 0% 6.19% 0%
2025/05/31 47.94% 23.84% 4.78% 4.04% 3.62% 1.81% 1.54% 0.66% 0% 0%

Copyright © Adthena. All rights reserved.

In May 2025, repatha.com dominated with a peak impression share of 54.06% on May 20. Meanwhile, repathahcp.com fluctuated, peaking at 34.29% on May 16. Thorne.com and nexlizethcp.com had minimal shares, while leqviohcp.com and naomiw.com showed modest activity. Farxiga.com spiked on May 10 with 21.01%, and nexlizet.com had a notable 8.15% on May 24. The month concluded with repatha.com leading at 47.94%.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Heart Failure Treatment Option - A Treatment For Heart Failure Prescription treatment website

    Learn About A Treatment That May Help Reduce The Risk Of Hospitalization For Heart Failure. Treating Heart Failure. HF Hospitalization Info.

  2. 2
    Can't Tolerate Statins? - Consider a Nonstatin Treatment

    If statins alone aren't enough or you can't take them, consider a nonstatin treatment. If you are at risk for a major heart event, find out...

  3. 3
    Repatha® (evolocumab) - Visit the Official Website https://www.repatha.com/

    Visit the Official Patient Website for Information on Repatha® As a Treatment Option. Find Dosing Options and Treatment Information by...

  4. 4
    Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/

    Learn More About Repatha by Visiting the Official Product Website for Physicians. Explore HCP Resources and Learn More About...

  5. 5
    VYNDAMAX® (tafamidis) - An FDA Approved Medication https://www.vyndamax.com/about

    Find Dosing Info, A Custom Discussion Guide, And Educational Resources About VYNDAMAX.®

Copyright © Adthena. All rights reserved.

In the competitive landscape of cardiology PPC ads, Farxiga, Nexlizet, Repatha, and Vyndamax stand out. Farxiga emphasizes heart failure risk reduction, while Nexlizet targets statin-intolerant patients. Repatha focuses on comprehensive treatment information for both patients and physicians, and Vyndamax highlights FDA approval and educational resources.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Pharmacology

US
Pharma & Biotech

US Research and Development

US
Pharma & Biotech

US Pulmonology

UK
Pharma & Biotech

UK Pharmacology